Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. (Q33854923)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. |
scientific article |
Statements
1 reference
Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. (English)
1 reference
Gulick RM
1 reference
McAuliffe V
1 reference
Holden-Wiltse J
1 reference
Crumpacker C
1 reference
Liebes L
1 reference
Stein DS
1 reference
Meehan P
1 reference
Hussey S
1 reference
Forcht J
1 reference
Valentine FT
1 reference
1 reference
Identifiers
1 reference